Product Information
CLOBETASOL EMOLLNT 0.05% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.2549 per GM under NDC 45802063732. Its NADAC has been published 656 times since Nov 28, 2013.
FDA first approved this application on Aug 14, 2012. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the clobetasol propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802063732
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA201402FDA Approved
8/14/2012
TE Code
AB2
On Market Since
2/1/2013
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL EMOLLNT 0.05% FOAM has been published 656 times since Nov 28, 2013, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2549 per GM |
|---|---|
| All-time high | $5.4094 (May 13, 2015) |
| All-time low | $1.7622 (Nov 19, 2025) |
| 52-week high | $2.4660 |
| 52-week low | $1.7622 |
| Median price | $3.2944 |
| Average price | $3.3620 |
| Largest weekly change | +46.3% (Aug 19, 2020) |
| Weeks tracked | 656 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 87% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOBETASOL EMOLLNT 0.05% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL EMOLLNT 0.05% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.2549 per GM (NDC 45802063732), effective Aug 19, 2026.
How has the price of CLOBETASOL EMOLLNT 0.05% FOAM changed over time?
Over the history we have for it, the NADAC for CLOBETASOL EMOLLNT 0.05% FOAM has declined 30.4%. It has been tracked across 656 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOBETASOL EMOLLNT 0.05% FOAM?
Since Nov 28, 2013, the NADAC for CLOBETASOL EMOLLNT 0.05% FOAM has ranged from a low of $1.7622 (Nov 19, 2025) to a high of $5.4094 (May 13, 2015), with a median of $3.2944 per GM.
Are there cheaper alternatives to CLOBETASOL EMOLLNT 0.05% FOAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL PROP 0.05% FOAM, is $0.2969 per GM — about 87% below CLOBETASOL EMOLLNT 0.05% FOAM.
Who manufactures CLOBETASOL EMOLLNT 0.05% FOAM?
CLOBETASOL EMOLLNT 0.05% FOAM (NDC 45802063732) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.